News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 223395

Friday, 06/12/2015 11:53:51 PM

Friday, June 12, 2015 11:53:51 PM

Post# of 347009
Scott Antonia : Peregrine Pharmaceuticals KOL

This gets a bit puzzling....but I'd argue it is related to Peregrine and the purchase by CBMG (where Scott Antonia sits as scientific advisor) of his patents just does not sit right, especially when I see Seeking Alpha writing a negative article just a few weeks earlier before Dr. Antonia placed onto CBMG scientific advisory board..... still more puzzle pieces to sift through but adding some below...

==========================================================

1) Dr. Antonia is Peregrines Pharmaceuticals KOL

2) He is listed, along with James J. Mule on a couple patents

H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTUTE, INC, UNIVERSITY OF SOUTH FLORIDA
Scott Joseph Antonia, James J. Mule

https://www.collectiveip.com/technology-transfer/university-of-south-florida/patents?fin=Scott+Joseph+Antonia

3) SA writes negative article (author was "short") about CBMG

April 7, 2015

http://seekingalpha.com/article/3054796-cellular-biomedicine-strong-sell-on-car-t-failure-dishonesty-allegations-and-stock-promotion-minus-94_6-percent-downside

4) Then Scott Antonia gets placed on CBMG scientific advisory board (which must have been known by SA when they wrote that negative article...)

April 30, 2015
..today announced the appointment of Scott J. Antonia, M.D, Ph.D. and Guoping Fan, Ph.D., as members of the newly established Scientific Advisory Board. Dr. Antonia will advise the company on immuno-oncology and Dr. Fan will advise the company on stem cell technology and its applications.

http://www.cellbiomedgroup.com/newsroom/new-members-to-scientific-advisory-board/

5) All of a sudden CBMG buys out some patents, which are Scott Antonias...

ASSET PURCHASE AGREEMENT
by and among

BLACKBIRD BIOFINANCE, LLC,
as Seller,

DR. SCOTT ANTONIA and SAM SHRIVASTAVA
as Principals,

CELLULAR BIOMEDICINE GROUP, INC.
as Parent,

CELLULAR BIOMEDICINE GROUP VAX, INC.
as Buyer

http://www.streetinsider.com/SEC+Filings/Form+8-K+Cellular+Biomedicine+For%3A+Jun+08/10647630.html

6) Then today CBMG had class action filed against them
http://www.businesswire.com/news/home/20150612005540/en/CBMG-INVESTORS-Glancy-Prongay-Murray-Announces-Filing#.VXuaGkb76So

7) Who the hell is Blackbird Biofinance... not much info given on these guys

http://www.bizapedia.com/oh/BLACKBIRD-BIOFINANCE-LLC.html

8) ... maybe these paths lead no where but anyone associated with Peregrine, especially a KOL in the spotlight is worth checking and maybe its a good idea for no collaborators to surface that Peregrine is working with because I think some would go out of their way to slow Peregrine down again...


... not sure if related but co-patent assignee with Scott Antonia = James Mule, whom was placed as SA on Jan 15, 2015 @ OXIS biotech but much of OXIS website not updated-including BOD

http://www.prnewswire.com/news-releases/oxis-biotech-inc-announces-appointment-of-dr-james-j-mule-to-scientific-advisory-board-300021006.html

http://www.oxis.com/products-and-technology.html

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y